Akari Therapeutics Plc

Research Akari Therapeutics Plc (AKTX) on Bullrun: market cap USD 11.09M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerAKTX
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 11.09M
• Financial periodFY2025
• Net income-USD 17.30M

Valuation Snapshot

latest market cap is USD 11.09M.

About Akari Therapeutics Plc

Akari Therapeutics, Plc, an oncology company, develops antibody-drug conjugates (ADC) for cancer-killing toxins. Its lead payload is PH1 to disrupt the function of spliceosomes and to trigger an immune response that leads to additional cancer cell killing.

Frequently asked questions

What is Akari Therapeutics Plc's market cap?

Akari Therapeutics Plc's market capitalization is USD 11.09M.

What does Akari Therapeutics Plc do?

Akari Therapeutics, Plc, an oncology company, develops antibody-drug conjugates (ADC) for cancer-killing toxins. Its lead payload is PH1 to disrupt the function of spliceosomes and to trigger an immune response that leads to additional cancer cell killing.